05:07 PM EST - Chemokine Therapeutics Corp. : cancelled a US$25-million financing, moved to slash its workforce 65 percent and saw the resignation of its chief executive. The company said it withdrew its plan for a public offering of shares and warrants, announced May 30, because of poor conditions in the capital market. Chemokine Therapeutics Corp.
shares T.CTI are trading down 4 cents at $0.23.
